REQUEST A DEMO
Total
USD $0.00
Search more companies

Longbio Pharma (Suzhou) Co., Ltd. (天辰生物医药(苏州)股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Longbio Pharma (Suzhou) Co., Ltd. Profile Updated: August 20, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Longbio Pharma (Suzhou) Co., Ltd. (天辰生物医药(苏州)股份有限公司) is an enterprise located in China, with the main office in Suzhou. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was incorporated on October 26, 2020. Its’ total assets recorded a growth of 52.82%.

Legal Address
Room 601, Area A, Kechuang Building, 33 Southeast Avenue, Changshu City
Suzhou; Jiangsu; Postal Code: 215500

Contact Details: Purchase the Longbio Pharma (Suzhou) Co., Ltd. (天辰生物医药(苏州)股份有限公司) report to view the information.

Basic Information
Registered Capital:
Purchase the Longbio Pharma (Suzhou) Co., Ltd. (天辰生物医药(苏州)股份有限公司) report to view the information.
Financial Auditors:
Purchase the Longbio Pharma (Suzhou) Co., Ltd. (天辰生物医药(苏州)股份有限公司) report to view the information.
Incorporation Date:
October 26, 2020
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
16.66%
Purchase this report to view the information.
13.18%
Purchase this report to view the information.
12.52%
Purchase this report to view the information.
9.19%
Purchase this report to view the information.
6.84%
Subsidiaries
Longyan Biotechnology (Shanghai) Co., Ltd
100%
Company Performance
Financial values in the chart are available after Longbio Pharma (Suzhou) Co., Ltd. (天辰生物医药(苏州)股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Total Operating Revenue
141.69%
Operating Profit
-49.15%
EBITDA
-52.26%
Net Profit/Loss for the Period
-27.86%
Total Assets
52.82%
Total Equity
N/A
Return on Equity (ROE)
N/A
Debt / Equity
N/A
Quick Ratio
1.12%
Cash Ratio
0.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?